Merck delivered a strong Q4 double beat, with robust pipeline momentum and a healthy new launch cycle. Read more on the ...

Merck & Co., Inc. extended Keytruda patent protection to 2029; its 40:30:30 strategy and QLEX migration target 18% total returns. See why MRK stock is a buy.

AZN misses Q4 EPS and sales estimates, but rallies after projecting mid-to-high single-digit revenue growth and low ...

Merck (NYSE:MRK) has received Health Canada approval for ENFLONSIA (clesrovimab), a monoclonal antibody for RSV prevention in ...

Merck & Co., Inc. (NYSE:MRK) is included among the 15 Best Wide Moat Dividend Stocks to Invest in. On February 4, Scotiabank ...

Moderna (NASDAQ: MRNA) has been on fire this year, with the biotech's shares up by 39% through Feb. 6. This isn't due to the ...

As of Tuesday, February 03, Burning Rock Biotech Limited’s BNR share price has dipped by 6.50%, which has investors ...

Merck (NYSE:MRK) received Health Canada approval for ENFLONSIA, its RSV preventive therapy for infants. The authorization ...

U.S. equity markets continue to march higher and at Goodreid our view remains unchanged. We believe that the cyclical bull market that started in October 2022 is still underway and returns in 2026 ...

We came across a bullish thesis on Merck & Co., Inc. on R. Dennis’s Substack’s Substack by OppCost. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc.’s share was trading ...

So let's leave the world of publicly traded companies and go to the only other institution that's analogous to the insular ...

Combined sales for the company's blockbuster GLP-1 drugs Zepbound and Mounjaro exceeded $1 billion, with each showing ...